Article
<i>GATA6</i>amplification is associated with improved survival of<i>TP53</i>-mutated pancreatic cancer
2023-03-08
Abstract excerpt
<h4>Background</h4> Molecular profiling of pancreatic adenocarcinoma (PDAC) demonstrates that genomic and transcriptomic features are associated with prognosis and chemosensitivity. We evaluated treatment outcomes by genetic alterations in TP53 and GATA6 to determine the prognostic and predictive impact of co-mutations, among patients with pancreatic cancer in New York’s largest healthcare system. <h4>Methods</h4>...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6274575a-62b5-5405-a4cf-41dc273b6c8c
- DOI
- 10.1101/2023.03.06.23286147
